AbbVie Inc., US00287Y1091

AbbVie stock heads into the open after a 0.8 percent gain

Published on 09/14/2026 at 07:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 11, 2026, AbbVie stock finished at USD 257.17 on the NYSE, up 0.8 percent. The move left the shares above the 50-day average of USD 254.46 and well over the 200-day average of USD 230.94.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie stock closed at USD 257.17 on the NYSE on September 11, 2026, up 0.8 percent from the prior session. The move left the shares above the 50-day average of USD 254.46 and the 200-day average of USD 230.94.

September 11, 2026 close

AbbVie Inc. (ISIN US00287Y1091, NYSE: ABBV) ended the session at USD 257.17 after trading between USD 257.17 and USD 257.17, with volume of 0 shares. The stock was also above the 52-week midpoint implied by the range of USD 190.75 to USD 267.47.

MarketBeat said on September 13, 2026 that AbbVie had set its Q3 2026 guidance at 3.840-3.880 EPS, while also noting the company last posted quarterly earnings on July 31, 2026. No dated company event for September 14, 2026 was substantiated in the search results.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70097113 | bgmi